Riskpilot← Back to searchSign inGet full accessLevVäl Ivanova AB
ABIn liquidationOrg 5591676571StockholmMedical specialists activities · NACE 8622Est. 20180 employees
Revenue 2025
SEK 0
EBITDA margin
—
+97% vs 2024
Equity ratio
-1187.4%
Financial strength
Net profit 2025
SEK -2K
+97% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -2K | +97% |
| Net profit | SEK -2K | +97% |
| Total assets | SEK 825 | -21% |
| Equity | SEK -10K | -19% |
| Employees | 0 | — |
Legal name
LevVäl Ivanova AB
Org number
5591676571
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
10 augusti 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget skall bedriva hälsoverksamhet, så som undervisning och föreläsning av hälsofrämjande aktiviteter och friskvårds- aktiviteter, tolk och översättare samt därmed förenlig verksamhet.
Address
Stockholm
Email
rubensson@advokatlaget.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 45 | 7 | −0 | −0 | 0 |
| Staff expenses | — | −0 | — | — | — |
| EBITDA | 2 | 2 | −5 | −50 | −2 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 2 | 2 | −5 | −50 | −2 |
| Net financials | — | 0 | 0 | 0 | −0 |
| Profit before tax | 2 | 2 | −4 | −50 | −2 |
| Tax | −0 | — | −0 | −0 | — |
| Net profit | 2 | 2 | −5 | −50 | −2 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 59 | 57 | 51 | 1 | 1 |
| Equity | 45 | 47 | 42 | −8 | −10 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 14 | 10 | 9 | 9 | 11 |
| Total debt | 14 | 10 | 9 | 9 | 11 |
EBITDA margin
-155000.0%
This company
15.8%
Market median
-981113% vs market
20212025
Equity ratio
-1187.4%
This company
38.2%
Market median
-3208% vs market
20212025
Return on equity
-155200.0%
This company
18.4%
Market median
-843578% vs market
20212025
Net profit margin
-155200.0%
This company
8.1%
Market median
-1916149% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
1.08×
This company
0.62×
Market median
-74% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ZN Liquidator | Liquidator | 2025 |
| Former (1) | ||
MI Chief Executive Officer | Chief Executive Officer | 2020 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Deputy Board Member | 2020 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LevVäl Ivanova AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maria Ivanova | Chief Executive Officer | 0 companies |
| Zachari Nicolaus Rubensson | Liquidator | 0 companies |
| Anna Cecilia Gårdefelt | Deputy Board Member | 0 companies |